Showing results (131-140 of 188) with videos related to
Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patientsL C Platanias, C B Miller, R Mick, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancerR L Schilsky, M E Dolan, D Bertucci, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancerR B Ewesuedo, L Iyer, S Das, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancerR A Humerickhouse, M E Dolan, D J Haraf, et al.The Journal of Clinical Investigation|March 21, 1998
Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomesL Iyer, C D King, P F Whitington, et al.Clinical Pharmacology and Therapeutics|October 1, 1993
Modulation of vinblastine resistance with cyclosporine: a phase I studyB L Samuels, R Mick, N J Vogelzang, et al.Journal of the National Cancer Institute|May 4, 1988
Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemiaH M Golomb, M J Ratain, A Fefer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1995
Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642)M E Costanza, D Berry, I C Henderson, et al.Seminars in Oncology|June 1, 1987
Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemiaH M Golomb, A Fefer, D W Golde, et al.The Pharmacogenomics Journal|June 6, 2012
Functional characterization of ABCC2 promoter polymorphisms and allele-specific expressionT D Nguyen, S Markova, W Liu, et al.Pageof 19